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Nucleic acids derived from microorganisms are powerful triggers for innate immune responses. Proteins
called RNA and DNA sensors detect foreign nucleic acids and, in mammalian cells, include RIG-I, cGAS, and
AIM2. On binding to nucleic acids, these proteins initiate signaling cascades that activate host defense
responses. An important aspect of this defense program is the production of cytokines such as type I
interferons and IL-1b. Studies conducted over recent years have revealed that nucleic acid sensors also
activate programmed cell death pathways as an innate immune response to infection. Indeed, RNA and DNA
sensors induce apoptosis, pyroptosis, and necroptosis. Cell death via these pathways prevents replication of
pathogens by eliminating the infected cell and additionally contributes to the release of cytokines and
inflammatory mediators. Interestingly, recent evidence suggests that programmed cell death triggered by
nucleic acid sensors plays an important role in a number of noninfectious pathologies. In addition to nonself
DNA and RNA from microorganisms, nucleic acid sensors also recognize endogenous nucleic acids, for
example when cells are damaged by genotoxic agents and in certain autoinflammatory diseases. This review
article summarizes current knowledge on the links between nucleic acid sensing and cell death and explores
important open questions for future studies in this area.
© 2019 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Introduction
DNA and RNA play fundamental roles in the
immune system [1]. Unusual and aberrantly loca-
lized nucleic acids are molecular signatures indica-
tive of the presence of microorganisms or of
perturbations to cellular homeostasis [2,3]. A variety
of mammalian, germ-line encoded proteins, called
nucleic acid sensors, bind directly to such DNA and
RNA species and then signal for the induction of host
defense responses. Examples are the Toll-like
receptors (TLRs) 3, 7, 8, and 9, the RIG-I-like
receptors (RLRs), cyclic guanosine-monophosphate
adenosine-monophosphate synthase (cGAS), and
absent in melanoma 2 (AIM2). These proteins have
been well studied in the context of infectious insults,uthor(s). Published by Elsevier Ltd. This
ses/by/4.0/).particularly viruses. Being obligate intracellular
pathogens, viruses need to introduce and replicate
their genetic material in the cells they infect. There-
fore, nucleic acid sensing is a broadly effective
strategy employed by host cells to detect invading
viruses. However, healthy cells contain a variety of
endogenous DNA and RNA species, necessitating
molecular mechanisms that prevent the activation of
nucleic acid sensors in the absence of infection.
These include: (i) recognition of nucleic acids in
subcellular compartments usually devoid of DNA or
RNA; (ii) detection of either the presence or absence
of chemical modifications on viral nucleic acids; (iii)
sensing of unusual nucleotide sequences or sec-
ondary and tertiary structures; (iv) recognition of
changes in DNA or RNA abundance; and (v)is an open access article under the CC BY license (http://
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regulating nucleic acid sensors [1,2]. Stress and
damage of cells, as well as mutationsdfor example,
in genes encoding nucleasesdsometimes result in
a breakdown of these mechanisms and subsequent
sensing of endogenous nucleic acids. This is
relevant in the context of autoinflammatory diseases
and in cancer [3e5].
Once activated by DNA or RNA, nucleic acid
sensors induce innate immune responses, the best
characterized of which is the induction of cytokines.
For example, TLRs, RLRs, and cGAS all activate
signaling cascades that transcriptionally induce the
genes encoding type I interferons (IFNs), which are
important mediators of antiviral immunity [6]. Another
example is the double-stranded (ds) DNA sensor
AIM2, which nucleates the formation of an inflam-
masome, leading to proteolytic maturation of IL-1b
and other cytokines [7]. Although cytokine produc-
tion plays an essential role in nucleic acidetriggered
host defense, other signaling outputs of nucleic acid
sensing have been described. PKR detects dsRNA
and then phosphorylates and thereby inhibits eIF2a,
a translation initiation factor [8]. This results in a
global shutdown of protein translation in virally
infected cells, preventing the production of viral
proteins. Much like PKR, OAS family proteins also
detect dsRNA following virus infection [9]. This
results in activation of the enzymatic function of
OAS proteins to produce 20-50 oligoadenylate, which
in turn activates RNase L. This nuclease then
cleaves cellular and viral RNAs and thereby prohibits
replication of RNA viruses.
Another distinct consequence of engagement of
nucleic acid sensors is the activation of programmed
cell death. Indeed, apoptosis, pyroptosis, and
necroptosis can all be initiated by DNA and RNA
sensors. These pathways are summarized in
Table 1. “Suicidal” cell death can be advantageous
to the host in a number of ways [10e12]. Firstly, it
prevents replication of intracellular pathogens by
elimination of infected cells. Secondly, some types of
programmed cell death such as pyroptosis result inTable 1. Overview of apoptosis, pyroptosis, and necroptosis.
Apoptosis
Cellular events cell shrinkage







a Selected examples, please see text for further details.the release of cytokines, particularly IL-1b. Thirdly,
when cell death involves damage to the plasma
membrane, as is the case during necroptosis and
pyroptosis, intracellular molecules such as ATP are
released into the extracellular space and serve as
damage associated molecular patterns [13].
Fourthly, cell death facilitates antigen uptake by
professional antigen presenting cells, thereby elicit-
ing adaptive immune responses [14]. Finally, cell
corpses can entrap and thereby disable pathogenic
microorganisms [11].
In this article, we discuss recent examples of how
nucleic acid sensors couple to programmed cell
death, focusing on some of the key questions in the
field: What are the mechanisms of self versus
nonself discrimination by nucleic acid sensors in
the context of cell death? What are the molecules
driving cell death downstream of nucleic acid
sensors? What is the importance of cell death
instructed by DNA and RNA sensors to host defense
against pathogens, in cancer and during autoin-
flammation? We will first explore DNA sensors and
then RNA sensors in separate chapters.DNA Sensors
Innate immune DNA sensors are DNA-binding
proteins that detect perturbations in cellular DNA
homeostasis and activate intracellular innate
immune signaling cascades [15]. These perturba-
tions can be caused by infection where foreign DNA
is introduced into cells, or by damage or mislocaliza-
tion of self-DNA, which is usually compartmentalized
in organelles. DNA sensors activate a wide range of
innate immune responses. DNA sensing is particu-
larly important in the context of viral infection where a
key innate immune response is the induction of type I
IFNs, which signal in an autocrine and paracrine
manner to establish an anti-viral state [6]. As such,
type I IFNs not only restrict viruses in the infected cell
but also limit the spread of viruses to surrounding
cells. In addition to type I IFN induction, several DNAPyroptosis Necroptosis
s
pore formation














554 Nucleic Acid Sensors and Programmed Cell Deathsensors and proteins involved in downstream
signaling activate programmed cell death as an
innate immune response to infection. This section
will focus on the role of DNA sensors in the activation
of programmed cell death pathways.
AIM2
The inflammasome is a large protein complex that
orchestrates oligomerization and activation of
caspase-1 by auto-proteolytic cleavage. Active
caspase-1 in turn cleaves and thereby matures the
pro-inflammatory cytokines IL-18 and IL-1b [16].
Inflammasome activation also results in the induc-
tion of pyroptosis, an inflammatory form of cell death
(Table 1). Pyroptosis involves cell swelling, lysis,
and ultimately the release of cytoplasmic content
[17].
AIM2 is a DNA sensor that activates the inflamma-
some [18e21]. AIM2 is cytosolic and contains a pyrin
domain and a HIN200 domain. HIN200 domains are
positively charged and bind to dsDNA in a sequence
independent manner [22]. On dsDNA binding, the
pyrin domain of AIM2 interacts with the pyrin domain
of the key inflammasome adaptor apoptosis-related
speck-like protein (ASC). ASC then nucleates an
inflammasome using its caspase activation and
recruitment domain (CARD) to associate with the
CARD of pro-caspase-1, triggering multimerisation
and autocatalytic cleavage to release active cas-
pase-1. This occurs in a large structure, the so-called
“ASC speck” that can be readily visualized by
microscopy [23e25]. Active caspase-1 subse-
quently catalyzes the processing of pro-IL-18 and
pro-IL-1b into the mature cytokines (Fig. 1A). The
active forms of these proinflammatory cytokines
mediate downstream inflammation and immune
responses once released from cells.
Pyroptosis kills cells through the action of gasder-
min D (GSDMD) [26,27], a substrate cleaved by
caspase-1 and other caspases. Full-length GSDMD
is in an auto-inhibited, inactive conformation. Clea-
vage by caspase-1 leads to the release of an N-
terminal GSDMD fragment (p30) that forms pores in
the cell membrane to execute pyroptotic cell death
[17,26e28]. GSDMD-mediated cytolysis is nega-
tively regulated by the endosomal sorting complexes
required for transport (ESCRT) machinery, which
can initiate repair of damaged membranes [29].
GSDMD is also regulated at the transcriptional level
by IRF2, which binds to a region within its gene
promoter to mediate transcriptional activation [30].
IL-18 and IL-1b are not released by the canonical
secretory pathway via the Golgi apparatus; instead,
that they can exit living cells through GSDMD pores
and are also released during pyroptotic cell death
when the plasma membrane ruptures [31e35].
GSDMD deficiency abrogates pyroptosis in
response to poly(dA:dT), a synthetic dsDNA that issensed by AIM2 [26,27]. AIM2 has been implicated
as a sensor of cytosolic DNA from invading DNA
viruses and bacteria, as well as self-derived cyto-
solic DNA [20,36,37]. AIM2 has also been implicated
in sensing of influenza A virus (IAV) infection [38].
IAV is an RNA virus. Interestingly, this study [38]
demonstrates that dsDNA released into the lungs of
infected mice, presumably from dying cells, is
sensed by AIM2 to activate caspase-1 and IL-1b.
Recognition of self-derived DNA by AIM2 is also
important in the context of radiation induced DNA
damage [39]. Ionizing radiation induces double-
stranded breaks in DNA. AIM2 localizes to these
double-stranded DNA breaks in the cell nucleus, and
the resulting inflammasome activation and cell death
causes tissue damage in mice [39]. Many of these
studies on AIM2 employ mice or murine cells.
Interestingly, in human myeloid cells, AIM2 is
dispensable for DNA-mediated inflammasome acti-
vation; instead, DNA sensing via the cGAS-STING
pathway induces NLRP3-dependent lysosomal cell
death and release of IL-1b [40].
In addition to pyroptosis, AIM2 also triggers
apoptosis. AIM2 is so-called because it was origin-
ally identified as a tumor suppressor, absent in
melanoma [41]. Indeed, loss-of-function mutations in
AIM2 are present in more than half of the tumors
from patients with bowel cancers, including color-
ectal cancers [42,43]. A recent study [44] demon-
strated a proapoptotic and antiproliferative effect of
AIM2, and further suggested that this is antagonized
by the prosurvival phosphatidylinositol-3-kinase
(PI3K)/protein kinase B (Akt) pathway in colorectal
cancer cells. The molecular mechanisms by which
AIM2 activates apoptosis in this context remain to be
elucidated. AIM2 can also induce apoptosis during
infection. AIM2 sensing of Toxoplasma infection
signals the activation of a noncanonical apoptosis
pathway that is GSDMD-independent and ASC- and
caspase-8-dependent [45]. Future studies are
needed to better understand how AIM2 drives
different forms of cell death and how this is species-
and cell type-dependent.
IFI16
Much like AIM2, IFNg-inducible protein 16 (IFI16)
comprises HIN200 and pyrin domains. AIM2, IFI16
and other proteins constitute the AIM2-like receptor
(ALR) family that has undergone species-specific
diversification [46]. IFI16 has been suggested to
function as a DNA sensor for both the induction of
type I IFN [47e49] and the inflammasome [50]. IFI16
can be both nuclear and cytoplasmic and in its
nuclear localization has been suggested to sense
herpes viral genomic DNA to activate the inflamma-
some [50e52]. IFI16 becomes acetylated on recog-
nition of viral DNA in the nucleus and is transported
into the cytoplasm in complex with breast cancer 1
Fig. 1. Cell death pathways triggered by DNA sensors. (A) The AIM2-like receptors AIM2 and IFI16 recognize dsDNA
and induce pyroptosis. AIM2 resides in the cytosol, while IFI16 can sense viruses such as KSHV in the nucleus.
Acetylation (Ac) of IFI16 promotes its nuclear export. KSHV antagonizes IFI16 by inducing its proteasomal degradation.
AIM2 and IFI16 bind to dsDNA via their HIN200 domains (HIN) and subsequently recruit ASC via Pyrin domain (PYD)
interactions. ASC contains a CARD domain, which interacts with the CARD of pro-caspase-1, forming a large molecular
weight complex called the “ASC-speck”. Autocatalytic cleavage of procaspase-1 results in the formation of active
caspase-1, which cleaves GSDMD releasing the cytotoxic N-terminal fragment (p30) that forms pores in the cell
membrane. Caspase-1 also cleaves pro-IL1b, leading to the maturation into its biologically active form. (B) The cGAS/
STING pathway detects the presence of dsDNA inside the cytosol and promotes antiviral immunity by inducing type I IFN
production. On binding of dsDNA, cGAS synthesizes the cyclic dinucleotide cGAMP, a ligand for the ER-resident protein
STING. cGAMP analogues, bacterial cyclic dinucleotides and other molecules such as DMXAA can also bind STING.
Activated STING recruits the kinase TBK1, which phosphorylates the transcription factor IRF3. IRF3 then dimerizes and
translocates to the nucleus where it controls type I IFN gene expression. STING also induces the activation of the pro-
inflammatory transcription factor NF-kB. Engagement of cGAS/STING can also induce cell death presumably via the cell-
intrinsic caspase-9 mediated apoptotic pathway. Active caspase-9 activates the executioner caspases 3 and 7. Other
outcomes of cGAS/STING stimulation include cellular senescence, inhibition of T cell proliferation and autophagy. The
signaling pathways that control these processes are poorly characterized.
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inflammasome by interacting with ASC to mediate
caspase-1 activation and IL-1b maturation (Fig. 1A).
This forms a key innate immune response to virus
infection as evidenced by the fact that Kaposi's
sarcoma herpes virus (KSHV) has evolved a
mechanism of antagonizing this by targeting IFI16
for degradation [53].
IFI16 has further been implicated in pyroptosis of
human immunodeficiency virus type-1 (HIV-1)-
infected CD4 T cells [54]. Acquired immunodefi-
ciency syndrome is caused by the progressive
depletion of CD4 T cells as a consequence of HIV-
1 infection. CD4 T cell depletion is associated with
inflammasome formation and subsequent caspase-1 activation and pyroptotic cell death [55]. These
CD4 T cells are generally quiescent by-stander cells,
which primarily reside in lymphoid organs [56]. The
restriction factor SAMHD1 is active in noncycling
cells, including quiescent CD4 T cells, reducing their
permissiveness to HIV-1 [57,58]. Nonproductive
HIV-1 infection of these cells results in an accumula-
tion of incomplete reverse transcripts in the cytosol.
IFI16 was identified as a sensor of this HIV-1 DNA
using an unbiased proteomic screen of tonsillar HIV-
infected CD4 T cell lysates [54]. Indeed, IFI16
silencing or pharmacological inhibition of reverse
transcription in resting human CD4 T cells prevents
caspase-1 activation and cell death following abor-
tive HIV-1 infection. This study further reports that
556 Nucleic Acid Sensors and Programmed Cell DeathIFI16 is localized in the cytosol of resting human
tonsillar CD4 T cells and that IFI16 immunoprecipi-
tates with HIV-1 Nef DNA [54].
A subsequent study [59] demonstrated that IFI16-
mediated pyroptosis is dependent on the mode of
viral spread. Specifically, direct cell-to-cell spread as
opposed to cell-free transmission of virus is required
to induce cell death of abortively infected CD4 T
cells. Furthermore, neither AIM2 (see above) nor
STING (see below) silencing rescues cell death in
HIV-1 infected tonsillar T cells [54]. These observa-
tions suggest that cell type and differentiation state,
as well as the route of virus entry, and perhaps other
aspects of viral life cycles, play important roles in
determining how dsDNA is sensed and the ensuing
downstream consequences.
cGAS-STING
The DNA sensor cGAS is essential for the type I
IFN response to cytosolic dsDNA derived from
microorganisms [15]. Active cGAS synthesizes the
second messenger cyclic guanosine monopho-
sphate-adenosine monophosphate (cGAMP) [60],
hence its nomenclature, cGAMP synthase. cGAMP
binds to and activates stimulator of IFN genes
(STING). Active STING then engages TANK-bind-
ing kinase 1 (TBK1), which in turn phosphorylates
the transcription factor IFN regulatory factor 3
(IRF3), leading to type I IFN gene transcription
[15] (Fig. 1B). Interestingly, cGAS has been
implicated in some autoinflammatory diseases and
may therefore sense endogenous DNA in these
settings [61e65]. Furthermore, the cGAS-STING
pathway is known to play an important role in
anticancer immunity and facilitates tumor-specific
adaptive immune responses [66,67]. STING ago-
nists have been proposed as adjuvants for vaccina-
tion and cancer therapy [68].
Several studies demonstrate that programmed
cell death, particularly apoptosis, can be activated
downstream of the cGAS-STING pathway. Natural
and artificial STING agonists, including variants of
cGAMP, induce intrinsic apoptosis in malignant B-
cells [69]. This is characterized by decreased
expression of the mitochondrial apoptosis inhibitor
protein MCL-1 and by increased cleavage of
caspases 3 and 9 as well as PARP, consistent
with intrinsic apoptosis [69] (Fig. 1B). STING
agonist induced apoptosis is not recapitulated by
treatment with recombinant IFNb suggesting that
this is unlikely to be an indirect effect of signaling
through the type I IFN receptor. In T cells, STING
activation blocks proliferation and triggers cell
death characterized by increased expression of
proapoptotic genes [70e72]. Mechanistically, it
has been suggested that activation of STING
disrupts calcium homeostasis and activates ERstress in T cells, which on engagement of the T
cell receptor undergo cell death [73]. In hepato-
cytes, endoplasmic reticulum stress triggers apop-
tosis in a STING- and IRF3-dependent manner
[74,75]. It will be interesting to determine whether
cGAS is required, too, or whether this represents
a function of STING independent of upstream
nucleic acid sensing [76]. A recent study sug-
gested that, when mitosis is arrested, cGAS
becomes activated with slow kinetics by genomic
DNA, resulting in apoptosis involving a transcrip-
tion-independent function of IRF3 [77]. Another
piece of evidence connecting the cytosolic DNA
sensing pathway to apoptosis stems from the
observation that human fibroblasts undergo
STING-dependent apoptosis on detection of DNA
from herpes simplex virus 1 (HSV-1) and human
cytomegalovirus (HCMV) [78]. Somewhat analo-
gous to the situation in resting T cells infected with
HIV, it has been suggested that reverse transcrip-
tion intermediates trigger cell death in Human T
Cell Leukemia Virus Type 1 (HTLV1) infected
monocytes [79]. In this case, however, the type of
cell death is apoptosis rather than pyroptosis and,
instead of IFI16, STING is required [79].
The relationship between the cGAS-STING path-
way and apoptosis is complex. It not only involves
direct activation of apoptosis by cGAS and STING,
but also the activation of cGAS in cells actively
undergoing cell-intrinsic apoptosis. Indeed, mito-
chondrial DNA released into the cytosol via BAX
and BAK-mediated permeabilization of the outer
mitochondrial membrane has been shown to acti-
vate cGAS [80e83]. However, it has been proposed
that apoptotic caspases block the pathway and
prevent the production of cytokines during apoptosis
[80,82]. Similarly, under conditions of pyroptosis,
cGAS is inactivated to prevent excessive cytokine
production, which may be due to multiple mechan-
isms [84,85].
The cGAS-STING pathway can additionally
induce necroptosis [86]. Indeed, intracellular DNA
sensing by cGAS in bone marrowederived macro-
phages and pharmacological STING activation in
vivo activate type I IFN and TNF signaling path-
ways, which synergize to trigger RIPK3- and MLKL-
driven necroptosis [86]. Moreover, cGAS-STING
activation by mitochondrial DNA released into the
cytosol has been suggested to amplify necroptosis
via a TNF-dependent mechanism [87]. In addition to
programmed cell death induction, the cGAS-STING
pathway has also been implicated in the induction
of autophagy [88e92] and in the regulation of
cellular senescence [93e95] (Fig. 1B). It will be
interesting for future studies to determine how
STING signaling can toggle between transcriptional
responses, different forms of cell death and
autophagy.
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Toll-like receptor 9 (TLR9) is an endosomal DNA
sensor that induces MyD88-dependent transcrip-
tional responses, mediated by NF-kB and IRF7
activation [96]. TLR9 has also been linked to cell
death. TLR9 is strongly activated by DNA molecules
containing unmethylated CpG dinucleotides, which
are commonly found in bacteria but are usually
methylated in vertebrates [97]. Stimulation of neuro-
blastoma cells with TLR9 ligands was found to
induce apoptosis [98]. Indeed, treatment with CpG
induces cell death that is characterized by cleavage
of caspase-3 and -7 and, which is rescued by the
pan-caspase inhibitor zVAD-FMK [98]. The authors
additionally observed depolarization of the mito-
chondrial membrane potential consistent with intrin-
sic apoptosis. In nude mice with neuroblastoma,
treatment with CpG prolongs long-term survival
suggesting an important potential application for
CpG oligonucleotides in cancer therapy [98]. The
use of nude mice, which lack a fully functioning
adaptive immune system, is consistent with T cell-
independent cytolysis of the cancer cells. A number
of other studies have linked TLR9 with apoptosis
induction and revealed that TLR9 is not only
proapoptotic, but also blocks apoptosis depending
on the cellular context [99e103]. For instance,
murine macrophages exposed to environmental
stress undergo increased apoptosis and deficiency
of TLR9 attenuates macrophage apoptosis and is
associated with down-regulation of caspase-3 and
PARP cleavage [102]. TLR9 activation has also
been implicated in immunopathogenic necrosis
during ischemic acute kidney injury, and in non-
apoptotic hepatocyte death mediated by RIPK1
[104,105]. Altogether, these results reinforce the
notion that the links between nucleic acid sensors
and cell death are highly cell-type specific.RNA Sensors
Much like the DNA sensors discussed in the
previous chapter, RNA sensors respond to foreign
nucleic acids derived from invading microorganisms
or to unusual endogenous RNA molecules [2]. Given
the presence of normal cellular RNA in many
different subcellular compartments, mechanisms of
self versus nonself discrimination are particularly
important for RNA sensors to avoid spontaneous
responses. Here, we discuss programmed cell death
as a consequence of the engagement of RNA
sensors.
RLRs
RIG-I-like receptors (RLRs) are a family of
cytosolic RNA sensors [2]. All three members ofthis protein family (RIG-I, MDA5 and LGP2) have a
helicase domain and a so-called C-terminal domain,
both of which bind to RNA. Additionally, RIG-I and
MDA5 have two N-terminal CARD domains. Binding
of immunostimulatory RNAs to the CTD and helicase
domains of RIG-I and MDA5 results in conforma-
tional changes that expose their CARD domains,
which then interact with the CARD domain found in
MAVS. This mitochondrial protein is an essential
adaptor for RLRs and mediates downstream signal-
ing, for example the induction of type I IFNs [2]
(Fig. 2A). The third RLR, LGP2, lacks CARD
domains and regulates the function of RIG-I and
MDA5 [2].
The properties of RNA molecules that are recog-
nized by RLRs and activation mechanisms have
been studied in detail, in particular for RIG-I [106].
Using its CTD and helicase domains, RIG-I surveys
the 50-ends of RNA molecules. A number of
biochemical features are detected, including (i) the
presence of an uncapped triphosphate (PPP) or
diphosphate (PP) group at the 50-end of the RNA
[107e109]; (ii) base-pairing of the 50-(P)PP contain-
ing RNA molecule to a complementary strand of
RNA [110,111]; and (iii) the absence of 20-O
methylation on the 50-terminal nucleotide [112].
These molecular features of RIG-I-stimulatory
RNAs are typically absent from the vast majority of
cellular RNAs in the cytosol but are found in several
viral RNA molecules, explaining selective activation
in virus infected cells. In addition, some cellular
noncoding RNAs normally found in the cell nucleus
have the properties of RIG-I-stimulatory RNAs, and
activate RIG-I when aberrantly localized in the
cytoplasm of an infected cell [113,114]. The features
of RNAs recognized by MDA5 are less well under-
stood and have been reviewed recently [115].
In addition to their essential role in type I IFN
induction during virus infection, RLRs have also
been described to induce apoptosis. RLR activation
can be triggered experimentally by cytosolic delivery
of synthetic RNA agonists such as poly(I:C), which
engages MDA5 and RIG-I, or 50-triphosphate con-
taining, base-paired RNAs that activate RIG-I [2].
Transfection of such RNAs into the cytosol of cells
not only results in type I IFN production but also in
the induction of apoptosis [116e118]. If activated
naturally by virus infection, RLR-triggered apoptosis
can be beneficial to the host by eliminating infected
cells [119]. Interesting translational approaches
have been suggested to harness RLR-mediated
apoptosis to eliminate cells persistently infected with
viruses and to kill cancer cells [120e123]. Stimula-
tion of RIG-I in breast cancer cells activates
pyroptosis, in addition to extrinsic apoptosis, thereby
promoting antitumor immune responses [123]. More-
over, RIG-I signaling has been implicated in the
activation of RIPK3-mediated necroptosis driven by
cooperative type I IFN and TNF signaling [86].
Fig. 2. Cell death pathways triggered by RNA sensors. (A) The RLRs RIG-I and MDA5 recognize 50 di- or
triphosphorylated short stretches of base-paired RNA and long complex dsRNA, respectively. Stimulation of RIG-I and
MDA5 exposes their CARDs, which interact with the CARD of MAVS. MAVS forms a multimeric complex localized at the
mitochondria, from where two distinct signaling pathways diverge. One complex contains the kinase TBK1, which
phosphorylates and activates the IRF3 transcription factor, which in turn controls expression type I IFN. MAVS also
stimulates the activation of the proinflammatory transcription factor NF-kB. A second complex forms with TRAF2, TRAF6,
and LUBAC and activates the RLR-induced IRF3 mediated pathway of apoptosis (RIPA). LUBAC adds linear ubiquitin
chains onto IRF3, which activates the proapoptotic protein Bax. This leads to leakage of cytochrome c out of the
mitochondria. Cytochrome c binds to and activates the proapoptotic protein Apaf-1, which induces the cleavage of the
proenzyme of caspase-9 into the active form. (B) ZBP1 contains two N-terminal Z-nucleic acid binding domains (Za1 and
Za2) through which it binds to Z-form dsRNA (Z-RNA). On activation, ZBP1 interacts with RIPK3 via homotypic RHIM
interactions. ZBP1 contains two tandem RHIMs (RHIM-A and RHIM-B), of which only RHIM-A is required for this
interaction. RIPK3 then phosphorylates MLKL, which on oligomerization triggers necroptosis by inducing permeabilization
of the cell membrane. In cells infected with IAV, RIPK3 also associates with RIPK1. RIPK1 contains a death domain (DD)
through which it recruits FADD. FADD associates with caspase-8 through death-effector domain (DED) interactions
leading to caspase-8 activation and apoptosis. In macrophages, ZBP1-mediated necroptosis or apoptosis triggers the
formation of a caspase-1 inflammasome leading to maturation of IL-1b. ZBP1 can also induce NF-kB activation and this
requires RIPK1 or RIPK3. The RHIM of RIPK1 prevents ZBP1-mediated necroptosis during development and in
keratinocytes. The mechanism through which RIPK1 prevents such “spontaneous” ZBP1 activation is unknown. (C) TLR3
is expressed on the cell surface (not shown) and in endosomes. The ligand-binding domain of TLR3 faces the endosomal
lumen and binds to dsRNA. TLR3 signals via TRIF that contains a RHIM, allowing recruitment of RIPK1 and RIPK3.
Interactions with RIPK1 stimulate NF-kB activation and proinflammatory gene expression. TRIF also signals via TBK1 and
IRF3 promoting type I IFN gene expression. RIPK1 can also associate with FADD and caspase-8 to induce apoptosis.
Active caspase-8 can directly cleave pro-IL1b into its biologically active form in TLR3-stimulated macrophages. When
caspase-8 activation is compromised, RIPK3 is recruited to TRIF and induces necroptosis by activating MLKL,
independently of RIPK1.
558 Nucleic Acid Sensors and Programmed Cell DeathMechanistically, apoptosis triggered by RLRs
requires MAVS and IRF3, much like IFN induction
[118,124]. However, MAVS has been suggested to
form two functionally distinct complexes with IRF3.
One mediates IRF3 phosphorylation by TBK1 and
subsequent transcriptional induction of type I IFNs.
The other complex additionally contains TRAF2,
TRAF6, and the linear ubiquitin chain assembly
complex (LUBAC) and modifies IRF3 by addition of
linear ubiquitin chains [124,125]. IRF3 then translo-
cates to mitochondria and together with the proa-
poptotic protein Bax triggers the cell intrinsicapoptosis pathway and cytochrome C release from
mitochondria [124,125]. This pathway has been
designated as “RIG-I-like receptor-induced IRF3
mediated pathway of apoptosis (RIPA)” [126]
(Fig. 2A). It will be interesting to determine whether
this pathway of IRF3-mediated apoptosis is specific
to the RLR pathway or is also activated downstream
of other nucleic acid sensors that signal to IFN
induction via IRF3; for example, apoptosis initiated
by cGAS and STING may involve a similar IRF3-
dependent mechanism [77,79]. Intriguingly, MDA5
may not only be involved in triggering apoptosis but
559Nucleic Acid Sensors and Programmed Cell Deathalso in the execution of apoptosis, this has been
suggested to involve cleavage of MDA5 [127].
ZBP1
Z-DNA binding protein 1 (ZBP1, also known as
DAI and DLM-1) is encoded by an interferon-
stimulated gene and was described as an antiviral
cytosolic DNA sensor inducing type I IFNs, hence its
widely used name DNA-dependent activator of IFN-
regulatory factors (DAI) [128]. Studies in Zbp1/
mice, however, did not support these findings [129];
ZBP1-deficient primary mouse embryonic fibroblasts
and bone marrow-derived dendritic cells respond
normally to dsDNA transfection into the cytosol and
ZBP1 knockout mice show no defects in T cell-
mediated and humoral immune responses when
immunized with DNA vaccines, which depend on
TBK1 and type I IFN signaling [129]. Moreover,
overexpression of ZBP1 in HEK293T cells only
modestly stimulates reporter constructs under con-
trol of promoter elements from type I IFN genes
[130e132]. Importantly, seminal studies by the Chen
lab have identified cGAS as a major cytosolic DNA
sensor inducing type I IFNs and antiviral immunity
[15].
These observations pointed to a different antiviral
mechanism of action. Mocarski and colleagues were
the first to show that ZBP1 induces necroptosis
when cells are infected with the b-herpesvirus
murine cytomegalovirus (MCMV) [133]. ZBP1 con-
tains two tandem RIP homotypic interaction motifs
(RHIMs) [130,131]. ZBP1 associates with and
activates the kinase RIPK3 via RHIM-RHIM interac-
tions, leading to phosphorylation of the pseudoki-
nase MLKL, which on oligomerization forms pores in
the plasma membrane causing necroptosis of the
infected cell [134] (Fig. 2B). Interestingly, ZBP1-
mediated cell death occurs independently of RIPK1
[135] setting it apart from TNF-induced necroptosis,
which requires the kinase activity of RIPK1 [136].
MCMV encodes viral inhibitor of RIP kinase activa-
tion (vIRA, also known as M45), which contains its
own RHIM and suppresses the execution of necrop-
tosis by preventing ZBP1-RIPK3 interactions
[133,135,137,138]. Detection by ZBP1 is important
in vivo as replication of M45 RHIM-mutant MCMV is
severely attenuated in wild-type mice, while it
efficiently infects mice deficient for RIPK3 or ZBP1
[133,135].
ZBP1 also acts an innate sensor inducing cell
death following Influenza A (IAV) and B virus
infection [139,140]. During influenza virus infection,
ZBP1 signaling is positively regulated by the
transcription factor IRF1 [141]. In primary mouse
embryonic fibroblasts and bone marrowederived
macrophages ZBP1 nucleates a RIPK3-containing
complex that contains MLKL, triggering necroptosis,
and FADD, which induces caspase-8 mediatedapoptosis [139,140,142]. In LPS-primed macro-
phages, ZBP1 drives NLRP3 inflammasome activa-
tion, pyroptosis and IL-1b secretion [140,143]
(Fig. 2B). It is not clear how both apoptosis and
necroptosis coexist in cell cultures infected with IAV
as these events are generally considered hierarch-
ical and mutually exclusive [144]. Also, whether this
phenomenon is regulated by viral factors that
antagonize programmed cell death as is the case
for MCMV remains to be determined. Two groups
have independently shown that IAV replication is
enhanced in ZBP1-deficient mice suggesting that
ZBP1-mediated cell death is an effective antiviral
strategy in vivo [139,140]. These studies, however,
report differently on the survival outcome after
challenge with a lethal dose of IAV. This discrepancy
may be due to the fact that different contributions of
immunopathology, host tolerance, and viral resis-
tance are a common source of variation in IAV
survival studies [145,146].
Most studies on ZBP1 so far have been conducted
in the mouse system. ZBP1/RIPK3-dependent anti-
viral cell death in human cells is less well character-
ized. In an unbiased approach to determine the
antiviral effects of more than 350 interferon-stimu-
lated genes, human ZBP1 was shown to prevent
replication of multiple viruses, including coxsackie B
virus, sindbis virus, hepatitis C virus, and vaccinia
virus [147,148]. The role of ZBP1 in vaccinia virus
infection was confirmed more recently [149]. Human
ZBP1 has additionally been shown to be involved in
the detection of herpes viruses [150e153] and IAV
[154].
ZBP1 contains two N-terminal Za domains (Za1
and Za2). Za domains are found in a few different
proteins and specifically bind to double stranded
RNA or DNA in the “zig-zag” or Z-conformation
[155]. IAV RNA genomes immunoprecipitate with
ZBP1, and ZBP1 has been shown to colocalize with
IAV viral nucleoprotein complexes [139,143]. We
and others recently showed that on MCMV infection
IE3-mediated transcriptiondbut not translationdof
viral genes contributes to activation of ZBP1, and
that newly synthesized RNA cross-links to ZBP1
[156,157]. These observations suggest that ZBP1 is
an RNA sensor, at least in the context of viral
infection. Activation of ZBP1 is dependent on its Za-
domains, which specifically bind to Z-form dsRNA
( Z - R N A ) a n d n o t t o A - f o r m d s RNA
[139,140,153,156,157]. Importantly, Za-domains
are essential in vivo as knock-in mice, which express
ZBP1 carrying point mutations in both Za-domains
that abrogate binding to Z-nucleic acids, do not
restrict M45-mutant MCMV, similar to complete
ZBP1 knockout animals [157]. Under physiological
conditions Z-RNA is unstable [158] and the transition
of A-form dsRNA into Z-RNA in living cells requires
stabilization, for example through protein-RNA inter-
actions. This may be the case in IAV viral
560 Nucleic Acid Sensors and Programmed Cell Deathribonucleoprotein complexes, where the winding of
IAV genomes around viral nucleoproteins may
induce the Z-conformation [159]. Alternatively, cer-
tain dsRNA helices are more prone to form Z-RNA
due to their sequence content [160]. Indeed, alter-
nating CG-, rather than AT-sequences more readily
transition into Z-form nucleic acids [161]. MCMV and
HCMV genomes are rich in CG-repeats and contain
overlapping transcription units on both DNA strands,
which give rise to viral dsRNA that may adopt the Z
conformation.
In addition to its role during virus infection, ZBP1
has been shown to activate RIPK3/MLKL-mediated
necroptosis in cells lacking RIPK1 [162,163].
RIPK1-deficient mice die shortly after birth as a
consequence of unchecked caspase-8-dependent
apoptosis and RIPK3/MLKL-mediated necroptosis
[164]. The RHIM-domain of RIPK1 selectively
suppresses necroptosis as embryos in which the
RHIM of RIPK1 is mutated develop RIPK3/MLKL-
dependent dermal inflammation, but do not exhibit
typical abnormalities associated with aberrant cas-
pase-8 activation [162,163]. Crossing these mice to
ZBP1 knockout animals rescues their perinatal
lethality. ZBP1-induced necroptosis also drives
skin inflammation in mice in which RIPK1 expression
was specifically abrogated in keratinocytes [163]. In
the absence of a functional RIPK1 RHIM, ZBP1 was
shown to interact with RIPK3 and induce its auto-
phosphorylation; however, these studies did not
detect ZBP1-RIPK1 interactions [162,163] and the
precise mechanism of action of how RIPK1 prevents
ZBP1 activation remains unknown. Interestingly,
interferon-induced expression of ZBP1 suffices to
trigger necroptosis of RIPK1 deficient cells in the
absence of a viral insult [165e167] and blockade of
caspase activity on ectopic expression of ZBP1
induces cell death [157]. These findings suggest that
sensing of endogenous Z-nucleic acid species by
ZBP1 may contribute to the inflammatory disease
seen in RIPK1 or caspase-8 deficient mice [164].
Collectively, these observations suggest that
sensing of Z-nucleic acids, including Z-RNA, by
ZBP1 contributes to viral clearance via the induction
cell death, and may also underlie the development of
inflammatory pathologies.
TLR3
Toll-like receptor 3 (TLR3) is expressed on the cell
surface and in the endosomal compartment and
recognizes dsRNA and the dsRNA mimic poly(I:C)
[168,169]. Physiological dsRNA ligands that stimu-
late TLR3 are generated during virus infection and
may originate from genomes of dsRNA viruses,
dsRNA replication intermediates or overlapping
transcripts of large DNA viruses [169,170]. TLR3
signals via TIR domain-containing adapter inducing
IFNb (TRIF) and, through NF-kB and IRF3, stimu-lates production of proinflammatory cytokines and
type I IFNs [171e174] (Fig. 2C). TRIF contains a C-
terminal RHIM and interacts with RIPK1 to activate
NF-kB [175]. RIPK1 can also form a complex with
FADD and caspase-8 to induce apoptosis
[176e179]. In macrophages, simultaneous TLR3
stimulation and inhibition of translation results in cell
death accompanied by caspase-8-mediated clea-
vage and release of IL-1b, independently of cas-
pase-1 [180]. When caspase-8 activity is
compromised, TLR3 signals via RIPK3 and MLKL,
independently of RIPK1, to induce necroptosis
[181,182] (Fig. 2C).
TLR3 is highly expressed in a subset of dendritic
cells specialized in cross-presentation of extracel-
lular antigens [183]. In these cells, TLR3 induces
important costimulatory signals for the induction of
cytotoxic T cell responses against virus-infected
cells [184]. Mutations in TLR3 or TRIF are associated
with encephalitis after infection with HSV-1 [185,186]
or IAV [187]. Furthermore, in IAV infected mice,
TLR3 contributes to immunopathology [188] and
triggers cell death in the lungs [189]. Cells from
patients with homozygous loss-of-function mutations
in RIPK1 exhibit impaired proinflammatory signaling
via TLR3 and the TNF receptor, resulting in
dysregulated cytokine secretion and a predisposition
to necroptosis [190].
TLR3 has been shown to induce cell death of
epithelial cells in the small intestine in response to
poly(I:C) administration [191] or after release of RNA
from cells damaged by ionizing radiation [192].
Endogenous dsRNA released from dying cells can
act as a danger signal [193] driving both beneficial
and detrimental inflammatory responses that occur
during tissue damage. For example, stimulation of
TLR3 by noncoding RNAs released from dying
keratinocytes aids tissue repair after exposure of
the skin to ultraviolet light [194] or wounding
[195,196]. In contrast, TLR3 signaling contributes
to tissue damage in mouse models of acute
respiratory distress syndrome [197], myocardial
infarction [198], and sepsis [199]. An important
question for future work will be whether TLR3-
mediated production of proinflammatory cytokines
or TLR3-induced cell death, or both, causes these
phenotypes.
In some cases, TLR3-induced cell death aggra-
vates disease by contributing to a self-propagating
cycle of inflammation. Mice deficient for the LUBAC
subunit SHARPIN develop chronic proliferative
dermatitis [200]. These animals develop severe
skin inflammation [201] due to early TNF-induced
cell death of keratinocytes in the absence of an intact
LUBAC [202,203]. The release of endogenous
dsRNA from dying cells subsequently triggers
TLR3-mediated cell death driving skin inflammation
with increasing severity. Accordingly, crossing
SHARPIN-deficient mice to TLR3 knockout mice
561Nucleic Acid Sensors and Programmed Cell Deathprevented cell death in the skin and ameliorated
disease [189]. Interestingly, TRIF signaling was
reported to contribute to skin inflammation in
epidermis specific RIPK1 knockout animals, sug-
gesting a role for TLR3 (or TLR4, another TLR that
signals via TRIF) in autoinflammatory skin disease
[204], although it appears that the relative contribu-
tion of ZBP1 in this setting is greater than that of
TRIF [163,204].
Age-related macular degeneration (AMD) is a
complex human disease leading to progressive
retinal deterioration ultimately causing blindness
[205]. Choroidal neovascularization followed by
vascular leakage damages the retinal pigment
epithelium (RPE). Surprisingly, small interfering
RNAs (siRNAs) targeting vascular endothelial
growth factor-A (VEGFA), which are clinically tested
to prevent angiogenesis, act through a TLR3-
mediated cell death pathway and inhibit neovascu-
larization in a sequence independent manner [206].
Indeed, siRNAs can serve as agonists of TLR3
expressed on the cell surface of both blood vessels
and lymphatic endothelial cells and induce apoptosis
in these cells [207]. It should be noted that the
application of siRNA-TLR3 induced cytotoxicitydat
least in AMDdshould be approached with caution
as this process also induced the degeneration of the
RPE itself [208].
Taken together, programmed cell death induced
by TLR3 stimulation occurs in the forms of apoptosis
and necroptosis. Sensing of viral or endogenous
dsRNA by TLR3 contributes to beneficial host
responses such as tissue repair and cytotoxic T
cell activation, but it also triggers inflammatory
disease. Finally, ligands that induce TLR3-mediated
cell death can be harnessed for their therapeutic
potential for example in AMD and possibly also for
treatment of cancers [209,210].Outlook
The examples discussed in this review illustrate
intimate connections between innate immune
nucleic acid sensors and programmed cell death
pathways. Recent work has demonstrated that cell
death often rivals more classical responses such as
cytokine production in terms of importance to host
defense against infectious or inflammatory insults. At
the same time, it has also become clear that these
connections are highly complex and variable
depending for example on disease context and cell
type. Our understanding of how divergent signaling
outcomes such as transcription of cytokine genes
and cell death are coordinated is at its infancy.
Posttranslational modifications such as linear ubi-
quitin appear to play an important role in this
decision [125,189].In addition to the three types of programmed cell
death discussed here (Table 1), other cell death
pathways such as NETosis, paraptosis, and oxeip-
tosis play important roles in host-pathogen interac-
tions [11,211,212]. It will be interesting to study the
role of nucleic acids sensors as putative upstream
activators of these pathways. Moreover, the list of
nucleic acid sensors coupling to cell death presented
in this article is not exhaustive; for example, several
NOD-like receptors have been reported to sense
nucleic acids, sometimes working together with
helicase proteins. This includes NLRP9b, which
senses RNA in conjunction with DHX9, as well as
NLRP3 that responds to IAV RNA [213,214]. It
seems clear that nucleic acid sensing and cell death
will remain a fertile area for future research for many
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